[HTML][HTML] An effective DNA vaccine platform for Middle East respiratory syndrome coronavirus

AS Cockrell, RS Baric - Annals of Translational Medicine, 2016 - ncbi.nlm.nih.gov
Middle East respiratory syndrome coronavirus (MERS-CoV) is an ongoing emerging
infectious disease across the Arabian Peninsula, with the majority of cases occurring in …

Development of Middle East respiratory syndrome coronavirus vaccines–advances and challenges

H Cho, JL Excler, JH Kim, IK Yoon - Human Vaccines & …, 2018 - Taylor & Francis
ABSTRACT Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is an emerging
pathogen with the potential to pose a threat to global public health. Sporadic cases and …

An overview of Middle East respiratory syndrome coronavirus vaccines in preclinical studies

N Zhang, J Shang, C Li, K Zhou, L Du - Expert review of vaccines, 2020 - Taylor & Francis
ABSTRACT Introduction Middle East respiratory syndrome coronavirus (MERS-CoV) causes
high mortality in humans. No vaccines are approved for use in humans; therefore, a …

Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial

K Modjarrad, CC Roberts, KT Mills… - The Lancet Infectious …, 2019 - thelancet.com
Summary Background Middle East respiratory syndrome (MERS) coronavirus causes a
highly fatal lower-respiratory tract infection. There are as yet no licensed MERS vaccines or …

Antibodies and vaccines against Middle East respiratory syndrome coronavirus

J Xu, W Jia, P Wang, S Zhang, X Shi… - Emerging microbes & …, 2019 - Taylor & Francis
ABSTRACT The Middle East respiratory syndrome coronavirus (MERS-CoV) has spread
through 27 countries and infected more than 2,200 people since its first outbreak in Saudi …

First clinical trial of a MERS coronavirus DNA vaccine

IK Yoon, JH Kim - The Lancet Infectious Diseases, 2019 - thelancet.com
Middle East respiratory syndrome (MERS) coronavirus is an emerging pathogen with
pandemic potential that continues to cause sporadic human disease 7 years after the first …

Middle East respiratory syndrome vaccine candidates: cautious optimism

C Schindewolf, VD Menachery - Viruses, 2019 - mdpi.com
Efforts towards developing a vaccine for Middle East respiratory syndrome coronavirus
(MERS-CoV) have yielded promising results. Utilizing a variety of platforms, several vaccine …

[HTML][HTML] MERS-CoV vaccine candidates in development: The current landscape

K Modjarrad - Vaccine, 2016 - Elsevier
Middle East respiratory syndrome coronavirus (MERS-CoV), an emerging infectious disease
of growing global importance, has caused severe acute respiratory disease in more than …

Middle East respiratory syndrome: current status and future prospects for vaccine development

L Du, S Jiang - Expert opinion on biological therapy, 2015 - Taylor & Francis
The outbreaks of Middle East respiratory syndrome (MERS) previously in Middle East and
recently in South Korea have raised serious concerns worldwide, reinforcing the importance …

Recent advances in the vaccine development against Middle East respiratory syndrome-coronavirus

CY Yong, HK Ong, SK Yeap, KL Ho… - Frontiers in microbiology, 2019 - frontiersin.org
Middle East respiratory syndrome (MERS) is a deadly viral respiratory disease caused by
MERS-coronavirus (MERS-CoV) infection. To date, there is no specific treatment proven …